Kim HJ - Search Results

1

Warfarin-induced eosinophilic pleural effusion.

Jo YM, Park TH, Jeong IH, Kim HJ, Ahn JH, Kim WJ, Cho YR, Baek HK, Kim MH, Kim YD. Jo YM, et al. Among authors: kim hj, kim wj, kim mh, kim yd. Korean Circ J. 2011 Feb;41(2):109-12. doi: 10.4070/kcj.2011.41.2.109. Epub 2011 Feb 28. Korean Circ J. 2011. PMID: 21430998 Free PMC article.

2

Polychlorinated dibenzo-p-dioxins, dibenzofurans and biphenyls in crucian carp (Carassius auratus) from rivers in Korea during 2000-2004.

Jeong GH, Kim HJ, Moon JY, Jeon SK, Joo CH, Choi K, Chang YS. Jeong GH, et al. Among authors: kim hj. Chemosphere. 2009 May;75(9):1221-5. doi: 10.1016/j.chemosphere.2009.01.062. Epub 2009 Feb 25. Chemosphere. 2009. PMID: 19246071

3

Effect of sodium bicarbonate administration on mortality in patients with lactic acidosis: a retrospective analysis.

Kim HJ, Son YK, An WS. Kim HJ, et al. PLoS One. 2013 Jun 5;8(6):e65283. doi: 10.1371/journal.pone.0065283. Print 2013. PLoS One. 2013. PMID: 23755210 Free PMC article.

4

Resistive index as a predictor of acute kidney injury caused by an angiotensin converting enzyme inhibitor or angiotensin II receptor blocker in chronic kidney disease patients.

Kim ES, Kim HJ, Kim YJ, Lee SM, Lee HJ, Cho DS, Son YK, Kim SE, Kim KH, An WS. Kim ES, et al. Among authors: kim yj, kim hj, kim se, kim kh. Kidney Res Clin Pract. 2013 Dec;32(4):158-63. doi: 10.1016/j.krcp.2013.09.002. Epub 2013 Nov 2. Kidney Res Clin Pract. 2013. PMID: 26877935 Free PMC article.

5

Structural effects of N-aromatic acyl-amino acid conjugates on their deconjugation in the cecal contents of rats: implication in design of a colon-specific prodrug with controlled conversion rate at the target site.

Kong H, Kim H, Do H, Lee Y, Hong S, Yoon JH, Jung Y, Kim YM. Kong H, et al. Biopharm Drug Dispos. 2011 Sep;32(6):343-54. doi: 10.1002/bdd.763. Epub 2011 Jul 29. Biopharm Drug Dispos. 2011. PMID: 21800327

6

Synthesis and evaluation of sulfate conjugated metronidazole as a colon-specific prodrug of metronidazole.

Kim H, Lee Y, Yoo H, Kim J, Kong H, Yoon JH, Jung Y, Kim YM. Kim H, et al. J Drug Target. 2012 Apr;20(3):255-63. doi: 10.3109/1061186X.2011.639024. Epub 2011 Nov 26. J Drug Target. 2012. PMID: 22118327

7

Susceptibility of glucocorticoids to colonic metabolism and pharmacologic intervention in the metabolism: implication for therapeutic activity of colon-specific glucocorticoid 21-sulfate sodium at the target site.

Kong H, Lee Y, Kim H, Hong S, Kim DD, Yoon JH, Jung Y, Kim YM. Kong H, et al. J Pharm Pharmacol. 2012 Jan;64(1):128-38. doi: 10.1111/j.2042-7158.2011.01386.x. Epub 2011 Nov 18. J Pharm Pharmacol. 2012. PMID: 22150680

8

Colon-specific delivery of celecoxib is a potential strategy to improve toxicological and pharmacological properties of the selective Cox-2 inhibitor: implication in treatment of familiar adenomatous polyposis.

Lee Y, Kim H, Kim W, Yoon JH, Jeong SH, Jung Y. Lee Y, et al. J Drug Target. 2012 Jul;20(6):524-34. doi: 10.3109/1061186X.2012.693498. Epub 2012 May 27. J Drug Target. 2012. PMID: 22632102

9

Glycyrrhizin enhances therapeutic activity of a colon-specific methylprednisolone prodrug against experimental colitis.

Lee Y, Jeong S, Kim W, Kim H, Yoon JH, Jeong SH, Jung Y. Lee Y, et al. Dig Dis Sci. 2013 May;58(5):1226-34. doi: 10.1007/s10620-012-2495-7. Epub 2012 Nov 29. Dig Dis Sci. 2013. PMID: 23192646

10

N-succinylaspart-1-yl celecoxib is a potential colon-specific prodrug of celecoxib with improved therapeutic properties.

Lee Y, Kim J, Kim H, Kang S, Yoon JH, Kim DD, Kim YM, Jung Y. Lee Y, et al. J Pharm Sci. 2012 May;101(5):1831-42. doi: 10.1002/jps.23082. Epub 2012 Feb 14. J Pharm Sci. 2012. PMID: 22334096

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

20,944 results

Search Page